Comments 1 - 12 of 12 Search these comments
I think the word of people being injured by the vaxx is getting around. It's too big to hide.
I don't know of anyone who suffered from the jab in any way.
I don't know of anyone who suffered from the jab in any way.
I don't know of anyone who suffered from the jab in any way.
Hospitals are not overwhelmed.
I don't know of anyone who suffered from the jab in any way.
By LAURAN NEERGAARD
Three doses of Pfizer’s COVID-19 vaccine offer strong protection for children younger than 5, the company announced Monday, another step toward shots for the littlest kids possibly beginning in early summer.
Pfizer plans to submit the findings to U.S. regulators later this week. The Food and Drug Administration already is evaluating an application by rival Moderna to offer two-dose vaccinations to tots — and set June 15 as a tentative date for its independent scientific advisers to publicly debate the data from one or both companies.
The news comes after months of anxious waiting by parents desperate to vaccinate their babies, toddlers and preschoolers, especially as COVID-19 cases once again are rising. The 18 million youngsters under 5 are the only group in the U.S. not yet eligible for COVID-19 vaccination.